PL342944A1 - Nucleic acid transfer vectors, compositions containing same and uses - Google Patents

Nucleic acid transfer vectors, compositions containing same and uses

Info

Publication number
PL342944A1
PL342944A1 PL99342944A PL34294499A PL342944A1 PL 342944 A1 PL342944 A1 PL 342944A1 PL 99342944 A PL99342944 A PL 99342944A PL 34294499 A PL34294499 A PL 34294499A PL 342944 A1 PL342944 A1 PL 342944A1
Authority
PL
Poland
Prior art keywords
nucleic acid
compositions containing
transfer vectors
containing same
acid transfer
Prior art date
Application number
PL99342944A
Other languages
English (en)
Inventor
Carole Ciolina
Daniel Scherman
Pierre Wils
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9803573A external-priority patent/FR2776669B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PL342944A1 publication Critical patent/PL342944A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL99342944A 1998-03-24 1999-03-19 Nucleic acid transfer vectors, compositions containing same and uses PL342944A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9803573A FR2776669B1 (fr) 1998-03-24 1998-03-24 Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations
US8584898P 1998-05-18 1998-05-18
PCT/FR1999/000643 WO1999049067A1 (fr) 1998-03-24 1999-03-19 Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations

Publications (1)

Publication Number Publication Date
PL342944A1 true PL342944A1 (en) 2001-07-16

Family

ID=26234216

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99342944A PL342944A1 (en) 1998-03-24 1999-03-19 Nucleic acid transfer vectors, compositions containing same and uses

Country Status (12)

Country Link
EP (1) EP1066396A1 (no)
JP (1) JP2002507429A (no)
KR (1) KR20010074456A (no)
CN (1) CN1292827A (no)
AU (1) AU758406B2 (no)
BR (1) BR9909044A (no)
CA (1) CA2323831A1 (no)
HU (1) HUP0102413A3 (no)
IL (1) IL138624A0 (no)
NO (1) NO20004648L (no)
PL (1) PL342944A1 (no)
WO (1) WO1999049067A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4803945B2 (ja) * 2000-05-26 2011-10-26 アバンテイス・フアルマ・エス・アー 固定化オリゴヌクレオチドを使用する三重らせん形態の精製
FR2871465B1 (fr) * 2004-06-15 2006-09-08 Centre Nat Rech Scient Cnrse Collections de composes tracables et leurs utilisations
US7943589B2 (en) 2005-06-03 2011-05-17 President And Fellows Of Harvard College siRNA microbicides for preventing and treating diseases
US7795380B2 (en) 2006-06-02 2010-09-14 University Of Iowa Research Foundation Compositions and methods for nucleic acid delivery
EP3427054B1 (en) * 2016-03-07 2025-01-08 Quidel Cardiovascular Inc. Immunoassay controls and the use thereof
RU2731513C2 (ru) * 2018-12-21 2020-09-03 Селл энд Джин Терапи Лтд Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов NOS2, NOS3, VIP, KCNMA1, CGRP, для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-NOS2, или Escherichia coli SCS110-AF/VTvaf17-NOS3, или Escherichia coli SCS110-AF/VTvaf17-VIP, или Escherichia coli SCS110-AF/VTvaf17-KCNMA1, или Escherichia coli SCS110-AF/VTvaf17-CGRP, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора
CN120936386A (zh) * 2023-03-24 2025-11-11 艾德赛瑞思股份有限公司 核定位多肽及其缀合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020698A1 (en) * 1991-05-17 1992-11-26 Uab Research Foundation Sequence specific dna binding drugs
US5670347A (en) * 1994-05-11 1997-09-23 Amba Biosciences Llc Peptide-mediated gene transfer
FR2731014B1 (fr) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa Molecules d'adn, preparation et utilisation en therapie genique

Also Published As

Publication number Publication date
AU758406B2 (en) 2003-03-20
IL138624A0 (en) 2001-10-31
EP1066396A1 (fr) 2001-01-10
WO1999049067A1 (fr) 1999-09-30
NO20004648D0 (no) 2000-09-18
CN1292827A (zh) 2001-04-25
HUP0102413A3 (en) 2003-09-29
CA2323831A1 (fr) 1999-09-30
KR20010074456A (ko) 2001-08-04
NO20004648L (no) 2000-09-18
BR9909044A (pt) 2000-12-05
AU3406200A (en) 2000-12-14
JP2002507429A (ja) 2002-03-12
HUP0102413A1 (hu) 2001-10-28

Similar Documents

Publication Publication Date Title
PL342081A1 (en) Novel quaternary ammonia compounds, compositions containing them and their application
IL131648A0 (en) Nucleic acid indexing
IL162274A (en) Nucleic acid and protein designated 193p1e1b and compositions containing the same
AU4289399A (en) Nucleic acid transfer phage
EP1117436A4 (en) NEISSERIA SPP. POLYPEPTIDES, NUCLEIC ACID SEQUENCE AND THEIR USE
PL339920A1 (en) Synergetic compositions comprising oxathiazine and benzothiophene-2-carboxamido-s,s-dioxide
IL130608A0 (en) Novel nucleic and amino acid sequence
PL342944A1 (en) Nucleic acid transfer vectors, compositions containing same and uses
IL148805A0 (en) Gene transfer vectors
GB9717932D0 (en) Estimation of nucleic acid
PL348513A1 (en) Novel nucleic acid transferring agents, compositions containing them and uses
GB9704643D0 (en) Chemical composition
HUP0102455A3 (en) Novel nucleic acid transfer agents, compositions containing same and uses
GB9817909D0 (en) DNA constructs
AU1728197A (en) Lipopolyamine compound, pharmaceutical composition and nucleic acid transfer vector containing same, and preparation method
ZA992262B (en) Vectors for transferring nucleic acids, compositions containing them and their uses.
AU4513599A (en) Nucleotide sequence
HUP0003585A3 (en) Gene coding for androctonine, vector containing same and transformed disease-resistant plants obtained
AU7790300A (en) Cd29 pig protein, nucleic acid coding for said protein and the applications thereof
GB9819600D0 (en) Chemical compositions
AU2846099A (en) 1,3,4-thiadiazolylazo dyes and ink compositions containing the same
GB9822490D0 (en) Nucleic acid
GB9823481D0 (en) Nucleic acid
GB9822216D0 (en) Gene transfer
AUPP704498A0 (en) Nucleic acid sequence

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)